# Phase I Trial of Silymarin for Chronic Liver Diseases

> **NCT00389376** · PHASE1 · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)** · enrollment: 56 (actual)

## Conditions studied

- Hepatitis C
- Non-Alcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** Silymarin
- **DRUG:** Silymarin
- **DRUG:** Silymarin
- **DRUG:** Silymarin
- **DRUG:** Silymarin
- **DRUG:** Silymarin
- **DRUG:** Silymarin

## Key facts

- **NCT ID:** NCT00389376
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-01
- **Final completion:** 2008-02
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2008-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389376, "Phase I Trial of Silymarin for Chronic Liver Diseases". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00389376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*